Presentations & Publications

Cancer Informatics for Cancer Centers (Ci4CC)
2022 Symposium Precision Medicine Application in Radiation Oncology

Keynote: Novel Technology for Optimizing Theranostics
DOWNLOAD
Prostate Cancer Foundation Scientific Retreat
2022 – Oral EPI-7386 in Patients with Metastatic Castration-Resistant Prostate Cancer: Results From the First-in-Human Dose Escalation Phase 1a Study
DOWNLOAD
European Society for Medical Oncology (ESMO) Congress
2022 – Comprehensive assessment of 18F-FDG PET/CT images of cancer patients improves predictions of survival
DOWNLOAD
2022 – Application of novel machine learning model in predicting survival in adrenocortical cancer
DOWNLOAD
American Society of Clinical Oncology (ASCO) Annual Meeting
2022 – Incorporation of intrapatient response heterogeneity using 18F-NaF PET/CT imaging improves outcome prediction models for metastatic prostate cancer patients
DOWNLOAD
American Association of Physicists in Medicine (AAPM) Annual Meeting
2022 – Impact of combining training data from multiple disease types on lesion detection performance in two CNN architectures
DOWNLOAD
2022 – Determination of generalizability for CT organ segmentation CNNs across scanner manufacturer
DOWNLOAD
American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) Symposium
2023- Automated Analysis of FDG-PET/CT Imaging to Monitor Heterogeneous Disease Response in Metastatic Castration-Resistant Prostate Cancer
DOWNLOAD
American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) Symposium
2022 – Quantitative assessment of PSMA imaging before and after 177Lu-PSMA-617 treatment in a Ph I/II trial
DOWNLOAD
Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
2022 – Automated detection and quantification of neuroendocrine tumors on 68Ga-DOTATATE PET/CT images using a U-net ensemble method
DOWNLOAD
2022 – Automated evaluation of disease on 68Ga-DOTATATE PET/CT images for long-term lesion tracking on 177Lu-DOTATATE therapy
DOWNLOAD
Society for Immunotherapy of Cancer (SITCI) Annual Meeting
2021 – AI assisted whole body assessment of immunotherapy response using [18 F]F AraG , a PET agent for activated T cells
DOWNLOAD
Australian Privacy Policy AIQ's software has been cleared for clinical use under 510(k) K173444. For details, including the applicable Indications for Use, see: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K173444